Skip to main content
. 2023 Apr 12;15:281–294. doi: 10.2147/CEOR.S404175

Figure 3.

Figure 3

Comparison of percent reduction of WAC price and percent adoption of biosimilars in the US. WAC Price does not include GTN discounts. The reference product is scored as 1.0.